Terry Gou organizes global alliance to combat breast cancer

Taipei (CNA) Taiwanese tycoon Terry Gou (???) announced on Sunday that the healthcare foundation he created will work with leading research institutes in Taiwan and other countries to combat breast cancer.

He has always been determined to "fight breast cancer with technology," Gou said during a press conference held by the Yonglin Healthcare Foundation in Taipei, while pledging to bring together the world's medical and academic sectors on a single platform to confront the world's most resilient disease of cancer.

On this occasion, the founder and chairman of Hon Hai Precision Industry Co. (??), the world's largest contract electronics maker, announced that the Yonglin foundation will form an anti-cancer alliance with National Taiwan University Cancer Center, China-based BGI and U.S-based Nantworks and HudsAlpha, as well as the biotech sector in Taiwan.

The alliance will work to determine the genomic code of breast cancer through life science, biotechnology, gene screening and analysis, Gou said.

The entrepreneur, whose first wife died of breast cancer in 2005, said "people should turn regret into strength."

"We believe (we) can bring happiness to humanity," Gou said, noting that business opportunities are less important than the chance to live. "Life is priceless," he stressed.

Addressing the anti-cancer alliance, Gou said breast cancer will be its first target, followed by leukemia.

Hon Hai's cooperation with BGI (????), known as the Beijing Genomics Institute prior to 2008, will be like an "Industry Party" joining hands with a "Healthcare Party" in the fight against cancer, he said.

BGI, headquartered in Shenzhen, Guangdong Province, China, is a genome sequencing center. It has been tasked with establishing a national gene databank on the mainland and working to apply its research results in genomics to medical healthcare and the germination of agricultural seeds.

At Sunday's press conference at Yonglin Biomedical Engineering Hall, BGI president Wang Jian (??) said that at the appropriate time, the company will present a plan to declare war on cancer, with research breakthroughs in technology and medical treatment.

He expressed hope that in the future cancer will become a chronic disease that can be better controlled.

"Our first objective is to make breast cancer a treatable and controllable disease like liver cancer in the shortest period of time," Wang said.

NantWorks is an American pharmaceutical company, which intends to bring innovation to healthcare by using digital technologies.

Also based in the United States, the HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology.

Source: Focus Taiwan News Channel